We are live on ! Find out more
AC

Adelphi Capital Portfolio holdings

AUM $3.21M
1-Year Est. Return 121.6%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+121.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$515M
AUM Growth
+$58.9M
Cap. Flow
+$20.2M
Cap. Flow %
3.92%
Top 10 Hldgs %
100%
Holding
3
New
Increased
2
Reduced
1
Closed

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$27.9M
2
RYAAY icon
Ryanair
RYAAY
+$8.35M

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$16.1M

Sector Composition

Rank Sector Weight
1 Technology 52.29%
2 Healthcare 28.67%
3 Industrials 19.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIS icon
1
Fidelity National Information Services
FIS
$22.5B
$269M 52.29%
1,828,727
+192,862
+12% +$27.9M
TAK icon
2
Takeda Pharmaceutical
TAK
$55.8B
$148M 28.67%
8,274,227
-882,088
-10% -$16.1M
RYAAY icon
3
Ryanair
RYAAY
$30B
$98M 19.03%
2,995,860
+268,610
+10% +$8.35M

Similar funds

Adelphi Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Adelphi Capital held 3 positions worth $515M, up 13% from $456M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adelphi Capital deployed $20.2M of net new capital in Q3 2020, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 48% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Takeda Pharmaceutical, an estimated $16.1M trimmed.

  • Adelphi Capital added most to Fidelity National Information Services in Q3 2020, an estimated $27.9M increase.
  • Adelphi Capital's biggest Q3 2020 reduction was Takeda Pharmaceutical, cutting an estimated $16.1M.
  • Adelphi Capital's ten largest holdings make up 100% of its $515M portfolio in Q3 2020.
  • Adelphi Capital opened 0 new positions and closed 0 in Q3 2020.
  • Adelphi Capital's portfolio value rose 13% quarter-over-quarter to $515M.

Based on Adelphi Capital's 13F filing for Q3 2020, filed 29 Oct 2020.